✦ LIBER ✦

PND3 EFFICACY AND TOLERABILITY OF NATALIZUMAB IN RELAPSING MULTIPLE SCLEROSIS; A META-ANALYSIS

✍ Scribed by S Nikfar; R Rahimi; A Rezaie; M Abdollahi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of natalizumab

✍ F. Sangalli; L. Moiola; S. Bucello; P. Annovazzi; A. Rizzo; M. Radaelli; G. Vite 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 238 KB

PND3 EFFICACY AND TOLERABILITY OF INTERF

✍ S Nikfar; M Abdollahi; R Rahimi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PND3 THE BUDGETARY IMPACT OF THE UTILIZA

✍ E Chiao; K Meyer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Effect of natalizumab on clinical and ra

✍ Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; C 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 170 KB

PND1 A Risk-Benefit Analysis of Natalizu

✍ A.R. Walker; B. Deniz; S.T. Alexopoulos; R. Arnold; D. Bates 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Cognitive impairments in relapsing-remit

✍ Prakash, R.; Snook, E.; Lewis, J.; Motl, R.; Kramer, A. 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 271 KB